contract

Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year

ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,…

3 months ago

HSBC launches Digital Merchant Services in India

MUMBAI, India, Oct. 16, 2025 /PRNewswire/ -- HSBC announced the launch of HSBC Digital Merchant Services in India, a comprehensive…

3 months ago

Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3%

Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for…

3 months ago

LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood

ANDERNACH, Germany, Oct. 13, 2025 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company today announces the…

3 months ago

DeAgentAI (AIA) Achieves $457M Valuation Following Binance Alpha and Futures Listing

SEOUL, South Korea, Sept. 19, 2025 (GLOBE NEWSWIRE) -- DeAgentAI, the decentralized AI agent infrastructure project, has reached a fully…

4 months ago

LEADING EUROPEAN PAYMENT PROVIDER, SIBS, SELECTS GEP’S PROCUREMENT SOFTWARE TO MANAGE SOURCE TO CONTRACT GLOBALLY AND DRIVE NEW VALUE

The Portuguese-based company, which operates in more than 25 countries across the world, will use GEP SMART to support its entire…

4 months ago

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

EAST RUTHERFORD, N.J., Aug. 25, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced…

5 months ago

Docusign Showcases Next-Gen AI and Agreement Management Innovation at Singapore Momentum Event

SINGAPORE, Aug. 14, 2025 /PRNewswire/ -- Docusign (Nasdaq:DOCU), the Intelligent Agreement Management company, today unveiled new AI-powered tools—including AI Contract Agents…

5 months ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

5 months ago

Satellogic Reports Second Quarter Financial Results

27% Increase in Revenue to $4.4 million Coupled with 41% Decrease in Operating Costs and Expenses in 2Q 2025 Poised…

5 months ago